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Abstract
Background: Blood cultures are a gold standard specific test for diagnosing many infections.
However, the low yield may limit their usefulness, particularly in low-risk populations. This study
was conducted to assess the utility of blood cultures drawn from ambulatory outpatients.
Methods: Blood cultures drawn at community-based collection sites in the Calgary Health Region
(population 1 million) in 2001 and 2002 were included in this study. These patients were analyzed
by linkages to acute care health care databases for utilization of acute care facilities within 2 weeks
of blood culture draw.
Results: 3102 sets of cultures were drawn from 1732 ambulatory outpatients (annual rate = 89.4
per 100,000 population). Significant isolates were identified from 73 (2.4%) sets of cultures from 51
patients, including Escherichia coli in 18 (35%) and seven (14%) each of Staphylococcus aureus and
Streptococcus pneumoniae. Compared to patients with negative cultures, those with positive
cultures were older (mean 49.6 vs. 40.1 years, p < 0.01), and more likely to subsequently receive
care at a regional emergency department, outpatient antibiotic clinic, or hospital (35/51 vs. 296/
1681, p < 0.0001). Of the 331 (19%) patients who received acute care treatment, those with
positive cultures presented sooner after community culture draw (median 2 vs. 3 days, p < 0.01)
and had longer median treatment duration (6 vs. 2 days, p < 0.01).
Conclusion: Blood cultures drawn in outpatient settings are uncommonly positive, but may define
patients for increased intensity of therapy. Strategies to reduce utilization without excluding
patients with positive cultures need to be developed for this patient population.
Background
Positive blood cultures are considered a gold standard
specific test for diagnosing and managing patients with
bacterial infections. However, with the exception of a few
infectious foci such as endocarditis or meningitis, their
low sensitivity usually limits their diagnostic utility. Sev-
eral hospital-based studies have indicated that blood cul-
tures are typically positive in less than 10% of bacterial
pneumonias, soft tissue infections, and urinary tract infec-
tions and as a result their performance may not be cost
effective [1-13]. One study in the 1970s identified that the
yield of blood cultures obtained in an emergency
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department was lower in those selected for ambulatory as
compared to hospital care [14]. However, such a distinc-
tion may not be relevant today as a result of healthcare
restructuring over the past decade that has seen a shift
toward care of sicker patients in the community. There are
no studies published that have investigated the utility of
blood cultures obtained from community-based outpa-
tient settings.
This study was undertaken to comprehensively evaluate
the occurrence of sampling, and rate and predictors of
positive blood cultures obtained from all community-
based outpatient collection sites in the Calgary Health
Region. We also sought to determine if positive blood cul-
ture results were associated with subsequent use of acute
care facilities for treatment, by performing a database link-
age to all emergency departments, hospitals, and outpa-
tient parenteral antibiotic clinics in this large Canadian
region.
Methods
Patient population
The Calgary Health Region (CHR) is a fully integrated,
publicly funded health system that provides virtually all
medical and surgical care to the one million residents of
the cities of Calgary and Airdrie and approximately 20
nearby small towns, villages, and hamlets. In the CHR,
Calgary Laboratory Services (CLS) receives all specimens
submitted for blood culture testing from all acute care
hospitals and 24 community collection sites in the region
[15]. This study included all blood samples submitted for
culture from outpatient community collection sites in the
CHR from January 1, 2001 to December 31, 2002. Sam-
ples submitted from all emergency departments, hospi-
tals, and hospital-based clinics were excluded. This study
was reviewed by the Conjoint Health Research Ethics
Board at the University of Calgary and Calgary Health
Region.
Study protocol
A laboratory-based cohort design with linkage to hospital
administrative databases was utilized. All blood cultures
submitted from community-based collection sites in the
CHR during the study period were identified by use of the
Cerner PathNet Classic version 306 (Kansas City, MO)
database at CLS. Basic demographic information includ-
ing age, gender, and community collection site location
and the organism cultured were exported. In order to
determine whether patients subsequently accessed an
acute care service in the CHR within two weeks of blood
culture draw, linkages to two regional databases were per-
formed. The Health Information Services database that
registers all emergency department and acute care hospital
admissions and the Home Parenteral Therapy Program
(HPTP) database that registers all patients treated with
outpatient intravenous antibiotic therapy in the CHR
were queried for all patient encounters [16].
For all patients receiving acute care services, the type, loca-
tion, and duration of care and the most responsible diag-
nosis was recorded. Because patients may be treated
through more than one acute care service, such as assess-
ment in an emergency department and subsequent admis-
sion to hospital, acute care encounters were classified in a
hierarchal fashion. These included emergency visit only,
HPTP clinic assessment (with or without emergency visit),
and admission to hospital (with or without emergency
and/or HPTP clinic treatment). Data from each of the
three databases was exported to Excel 2000 (Microsoft
Corp., Redmond, WA) and merged using Access 2000
(Microsoft Corp.).
Laboratory procedures and definitions
All blood was cultured at CLS using the BacT/Alert auto-
mated instrument (Organon Teknika, Durham, NC). A
blood culture set consisted of an aerobic/anaerobic bottle
pair of BacT/Alert FAN bottles obtained from a single
draw [17]. Inoculated bottles were immediately placed in
the instrument, incubated at 37°C and continuously read
for growth in BacT/Alert 2-D cabinets. A significant isolate
was defined as the growth of a pathogenic organism from
at least one set of blood cultures. At least two positive sets
of blood cultures within a 48 hour period were required
to classify common contaminants including coagulase
negative staphylococci, viridans group streptococci, or
Bacillus,  Corynebacterium, or Propionibacterium species as
significant. Significant isolates were identified and tested
for antimicrobial susceptibility according to National
Committee for Clinical Laboratory Standards guidelines.
Antibiotic resistant organisms were defined as methicillin
resistant Staphylococcus aureus, vancomycin resistant Ente-
rococcus faecalis or faecium, Streptococcus pneumoniae with
reduced susceptibility to penicillin, or any Gram-negative
organisms resistant to ciprofloxacin, tobramycin, gen-
tamicin, ceftazidime, or carbapenems.
Analysis
The base dataset that included all culture draws was used
to describe blood culture sampling rates in the region. If a
patient had multiple blood cultures submitted they were
deemed to represent distinct "episodes" if different sets
were drawn greater than two calendar days apart. In the
assessment of demographic and outcome information,
the analysis was restricted to include only a given patient's
first episode. This was performed to avoid analysis of cor-
related measures due to repeat patient presentations/epi-
sodes.
All analyses were performed using Stata version 7.0 (Stata
Corp., College Station, TX). Variables were assessed usingBMC Infectious Diseases 2005, 5:35 http://www.biomedcentral.com/1471-2334/5/35
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histograms prior to analysis to identify outlying data
points and to assess underlying distribution. Means with
standard deviations (SD) were used to describe normally
or near normally distributed variables and medians with
interquartile ranges (IQR) for non-normally distributed
variables. Differences in proportions were compared
using Fisher's exact test. Means were compared with the
Student t test and medians using the Wilcoxon Rank-sum
test. Incidence and relative risk (RR) calculations with
exact 95% confidence intervals (CI) were performed as
previously described [18]. For these calculations we
assumed that patients were CHR residents if patients had
Alberta health care numbers and cultures were drawn at
CHR collection sites.
Results
Occurrence of sampling
During the study period, 3102 sets of blood cultures were
drawn from 1732 patients for an annual rate of sampling
of 89.4 per 100,000-health region residents. A single
blood culture only was taken on 371 patients (21%). The
rest had two or more sets of blood cultures drawn includ-
ing 79 (5%) with three sets, 62 with four sets, 18 with five
sets, and 14 with six sets. Two patients had seven sets and
one patient each had eight to 14 sets submitted. During
2001 and 2002 a total of 1567 and 1535 sets of cultures
were submitted from 895 and 837 patients for annual
incidences of culturing of 93.4 and 85.6 per 100,000 pop-
ulation (p = 0.04), respectively. The mean ± SD age of
patients was 40.2 ± 22.6 years overall and there was sub-
stantial variability in performance of first episodes of
blood culturing based on age as shown in figure 1. There
was a similar rate of culturing among males and females
with annual incident culturing rates of 89.9 and 91.8 per
100,000 (p = 0.3), respectively. However, among patients
65 years or older, males were more likely to be sampled
than females (179.9 vs. 139.6 per 100,000; RR = 1.3; 95%
CI, 1.01 to 1.64; p = 0.02).
Rate and etiology of positive cultures
Of the total 3102 sets of blood cultures, 108 (3.5%) grew
an organism and only 74 (2.4%) of these were deemed to
represent significant isolates. The 34 (1.1%) contami-
nants included coagulase negative staphylococci in 25
sets, two sets each of Micrococcus species, viridians group
streptococci, and Bacillus species, and one set each of gram
positive bacilli, Streptococcus mitis, and coryneform bacilli.
Significant isolates were identified from 73 sets of cultures
from 51 patients at first episode and these were most com-
monly Escherichia coli in 18 (35%) and seven (14%) each
of Staphylococcus aureus (co-isolated with group A strepto-
coccus in one case and streptococcal species in another)
and Streptococcus pneumoniae patients as shown in table 1.
Only one patient had an infection on a second or subse-
quent episode of blood culturing. This 76 year old man
had an Escherichia coli bacteremia at a second culturing
episode two months after he had a negative set of cultures
drawn.
Of the 24 patients with an aerobic Gram-negative rod bac-
teremia, a urine culture was not done in seven cases, had
discordant (negative) results in seven cases, and was con-
cordant (positive with identical isolate) in 10 cases. The
one patient with an extended spectrum beta-lactamase
producing E. coli had a concordant urine sample. The one
patient with Pseudomonas aeruginosa bacteremia had no
other cultures collected. All isolates of S. aureus were
methicillin susceptible. In eight (16%) patients with pos-
itive cultures, the anaerobic bottle was independently pos-
itive and the organisms were all facultative anaerobes (E.
coli in five and one each of Klebsiella pneumoniae, Proteus
mirabilis, and S. aureus).
Predictors and outcomes associated with positive blood 
cultures
A number of demographic, clinical, and outcome charac-
teristics were associated with blood culture positivity and
are shown in table 2. Patients with positive cultures were
of significantly higher mean age (table 2) with those aged
50 years or more likely to have a positive culture as com-
pared to younger patients (RR 1.6, 95% CI, 1.3 to 2.1, p <
0.01). Although only 252 (15%) patients had blood cul-
tures submitted at the main high volume lab location,
Table 1: Infectious etiology among 51 patients identified with 
community-based blood cultures first episodes, Calgary Health 
Region, Alberta, Canada (2001 and 2002).
Species Occurrence (n = 54*)
Escherichia coli 18 (35%)
Staphylococcus aureus 7 (14%)
Streptococcus pneumoniae 7 (14%)
Group A streptococcus 4 (8%)
Klebsiella pneumoniae 3 (6%)
Coagulase negative staphylococci 3 (6%)
Dialister pneumosintes 1 (2%)
Bacteroides fragilis 1
Abiotrophia species 1
Neisseria meningitidis 1
Peptostreptococcus species 1
Proteus mirabilis 1
Pseudomonas aeruginosa 1
Salmonella species group C2 1
Streptococcus mitis group 1
Streptococcus milleri group 1
Streptococcus sanguis group 1
Streptococcus species 1
Note: * Numbers do not add to 51 because three patients had 
polymicrobial infection; one each of Staphylococcus aureus/
streptococcal species, Staphylococcus aureus/group A streptococcus, 
and Escherichia coli/Bacteroides fragilis.BMC Infectious Diseases 2005, 5:35 http://www.biomedcentral.com/1471-2334/5/35
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nearly one third (16/51) of all positives cultures were
from that site (p < 0.01).
Of the cohort of 1732 patients who had a first episode of
blood cultures submitted, 331 (19%) subsequently
received acute care treatment within two weeks of culture
draw. One hundred and fifty-six patients were seen at an
emergency department only, 17 were treated via an HPTP
clinic (with or without emergency visit), and 158 patients
were admitted to hospital (with or without emergency
and/or HPTP clinic care). Patients with positive blood cul-
tures utilized acute care services at a significantly higher
rate, presented earlier, and had longer treatment dura-
tions (table 2). The increased use of acute care services was
largely due to a nearly six-fold increased admission rate
among those with positive as compared to negative cul-
tures (RR 5.9, 95% CI 4.2 to 8.2, p < 0.0001). Patients
with positive cultures presented earlier to acute care serv-
ices following culture draw from an outpatient collection
site than those with negative cultures and this was prima-
rily due to a significantly increased rate of presentation on
the second calendar day after blood culture draw.
Although there was no difference in the proportion pre-
senting the same calendar day (10/35 vs. 74/296, p = 0.7),
significantly more patients with positive cultures were
seen within two calendar days (< 48 hours) from the point
of culture draw (27/35 vs. 147/296, p < 0.01).
Based on emergency, HPTP clinic, or admissions data, the
most common recorded primary diagnoses were appar-
Annual age and gender related blood culture sampling incidence at community-based outpatient collection sites, Calgary Health  Region, Alberta, Canada (2001 and 2002) Figure 1
Annual age and gender related blood culture sampling incidence at community-based outpatient collection sites, Calgary Health 
Region, Alberta, Canada (2001 and 2002).
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ently non-infectious (22%), suspected non-focal or viral
infection (18%), and respiratory tract infection (18%) as
shown in table 3. There was an overall significantly differ-
ent proportional distribution of diagnoses among
patients with positive as compared to negative blood cul-
tures (p = 0.001). Patients with positive blood cultures
were more likely to be diagnosed with a genitourinary (RR
= 2.9, 95% CI, 1.5 to 5.7, p < 0.01) or cardiovascular (RR
= 6.7, 95% CI, 1.9 to 24, p < 0.01) focus as compared to
patients with negative cultures (table 3).
Discussion
This is the first study to comprehensively evaluate the util-
ity of blood cultures drawn from community-based out-
patients. We showed that the performance of blood
cultures on outpatients is a relatively common practice in
our region. This may in part be related to the considerable
healthcare restructuring that has occurred in recent years
with an increased emphasis on care of patients in the
community. Our positivity rate of 2.4% is similar to that
of 1.8% found by Sturmann et al [11] in patients dis-
charged from the emergency room. However, we do not
have comparative data from the prior era to demonstrate
that possibility. It is noteworthy that although there was
an increasing age specific rate of performance of blood
cultures in our population, this practice included a broad
range of patients from infants to the elderly. One collec-
tion site had a higher number of positive cultures. We sus-
Table 2: Demographic characteristics and acute care management of patients with blood cultures submitted to outpatient collection 
sites, Calgary Health Region, Calgary, Alberta (2001 and 2002).
Characteristic Positive cultures (n = 
51)
Negative cultures (n = 
1681)
Total (n = 1732) P-value*
Mean age ± standard 
deviation (years)
49.6 ± 21.1 40.1 ± 22.6 40.3 ± 22.6 < 0.01
Male gender 30 (59%) 829 (49%) 859 (50%) 0.2
Collection at high volume 
(main) lab vs. other sites
16 (31%) 236 (14%) 252 (15%) < 0.01
Acute care usage within 
two weeks of culture
35 (69%) 296 (18%) 331 (19%) < 0.0001
Emergency department 9 (18%) 147 (9%) 156 (9%) 0.04
HPTP clinic 2 (4%) 15 (1%) 17 (1%) 0.08
Admitted to hospital 24 (47%) 134 (8%) 158 (9%) < 0.0001
Median days of acute care 
therapy
6 (IQR = 2, 14; n = 35) 2 (IQR = 1, 6; n = 296) 2 (IQR = 1, 6; n = 331) < 0.001
Median time (days) to 
acute care assessment
2 (IQR = 1, 2; n = 35) 3 (IQR = 2, 5; n = 296) 2 (IQR = 1, 5; n = 331) < 0.01
Note: * p-value for comparison between those with positive and negative cultures using Fisher's exact test, Student's T test, and Wilcoxon Rank-
sum test for comparison of proportions, means, and medians, respectively.
Table 3: Primary diagnoses among 331 patients assessed at acute care sites following performance of outpatient blood cultures, 
Calgary Health Region, Alberta, Canada (2001 and 2002).
Primary diagnosis Positive cultures (n = 
35)
Negative cultures (n = 
296)
Total (n = 331) P-value*
No focus/virus 6 (17) 55 (18) 61 (18%) 1.0
Non-infective 4 (11) 70 (23) 69 (22%) 0.1
Soft tissue 1 (3) 35 (11) 31 (10%) 0.1
Bone/joint 1 (3) 11 (4) 12 (4%) 1.0
Respiratory 5 (14) 55 (20) 60 (19%) 0.6
Gastrointestinal 4 (11) 38 (13) 40 (13%) 1.0
Genitourinary 9 (26) 26 (9) 33 (11%) < 0.01
Vascular 4 (11) 5 (2) 9 (3%) < 0.01
Central nervous system 1 (3) 1 2 (1%) 0.2
Note: * p-value for comparison between those with positive and negative cultures using Fisher's exact test.BMC Infectious Diseases 2005, 5:35 http://www.biomedcentral.com/1471-2334/5/35
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pect this may be due to this site serving the urban poor
population of the region.
In addition to its novelty as the first outpatient study of
the utility of blood cultures, this study is also notable for
its comprehensiveness of case identification and assess-
ment of acute care utilization. Since all routine blood cul-
tures are processed by CLS in our region and they are
worked up and reported routinely using the CLS compu-
ter system, the number of patients having outpatient
blood cultures that may have been missed by our study is
negligible. It is also unlikely that we missed significant
patient encounters in acute care settings because we per-
formed a linkage to all institutions in the region. This
included 496,141 emergency department, 6,462 HPTP
clinic, and 189,897 hospital admissions over the two-year
study period.
An important finding of this study is that while the rate of
outpatient blood culture positivity was very low (2.4%),
when positive, these results appeared to have had a signif-
icant association with patient management. Patients with
positive cultures were more likely to receive acute care
treatment, present earlier after culture draw, and be
treated longer than patients with negative results. How-
ever, it is not clear from this retrospective observational
study whether patient's management changed as a result
of the culture or whether the differences observed were
related to an increased severity of disease associated with
a positive culture. Most studies have found that the posi-
tive blood cultures rarely result in a change in patient
management [4,5,11,13,19,20]. However, in more recent
studies on patients discharged from emergency rooms in
Spain [21] and Israel [22], over a third of patients with
positive blood cultures required either an initiation or
change in antimicrobial therapy.
A central issue surrounding the performance of blood cul-
tures in community-based settings is whether they are cost
effective. Several studies that have looked at the low yield
of blood cultures in a number of clinical settings and have
suggested poor cost effectiveness for this test especially
when the rate of positivity is low [3-5,11]. Arguments
against the use of blood cultures in these settings based on
poor cost effectiveness, however, have to be balanced
against the risk of using excessively broad or inadequate
empiric treatment. Based on the cost of USD$50 per aero-
bic and anaerobic set of blood cultures as determined by
Perl et al [5], approximately $75,000 per year (or $1014
per significant positive set of blood cultures) is required to
provide outpatient blood culture services in our region. As
noted previously, it is not clear whether these tests specif-
ically led to improvements in patient management.
There may be opportunities to better utilize outpatient
blood cultures in our region. First, in patients with a clin-
ical focus of infection such as pyelonephritis or cellulitis,
clinical features alone or with other routine cultures (such
as urine culture) may be enough to administer
appropriate treatment. In our positive cohort, seven cases
of urinary tract infections had positive blood cultures and
negative urine cultures. This is a higher rate of discordance
than in prior studies [8,12,19], which we feel is a conse-
quence of antibiotic therapy before the collection of urine
cultures. We agree with other investigators [8,12,23] that
urine culture prior to antibiotics should be the primary
diagnostic test with blood cultures being used selectively.
Second, the use of an anaerobic in addition to aerobic
bottle appears to provide relatively little added informa-
tion and may not be required routinely. The anaerobic
bottle was the only positive bottle in 8/1732 (0.5%)
patients cultured. In 5/6 of these cases (where informa-
tion was available) the diagnosis was urinary tract infec-
tion, and the etiology may have been available from urine
cultures. In the remaining case, the isolate was S. aureus
from a patient with a bone/joint source of infection. We
therefore agree with Morris et al [24] that anaerobic blood
cultures can be used selectively.
Finally, it is unclear whether blood culture results lead
physicians in the region to reduce broad spectrum or inap-
propriate antibiotic usage. Although we are unable to
address the practice in the region based on our study, sev-
eral reports have suggested that physicians do not com-
monly alter their management accordingly [3,25]. Further
prospective studies are required to better define means of
identifying patients that may benefit most from the per-
formance of outpatient blood cultures, including the use
of clinical scoring systems[26,27] and/or screening tests
[28-30].
Conclusion
This study documents the use of blood cultures obtained
from outpatients in community-based settings. Signifi-
cant positive results are rare (only 2.4%). Patients with
positive cultures do however, access acute care services
more frequently than those with negative cultures and are
more likely to be admitted to hospital. Further studies in
community-based populations are required to define
which patients are likely to benefit from blood cultures in
this setting.
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